Maravai LifeSciences Holdings, Inc. Variable Lease, Cost
Maravai LifeSciences Holdings, Inc. (MRVI) reported Variable Lease, Cost of $3.96 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-02-26
- Maravai LifeSciences Holdings, Inc. variable lease, cost for the quarter ending 2023-12-31 was $1.02M, a 15.61% increase year-over-year.
- Maravai LifeSciences Holdings, Inc. variable lease, cost for the quarter ending 2023-09-30 was $1.02M, a 29.24% increase year-over-year.
- Maravai LifeSciences Holdings, Inc. variable lease, cost for the quarter ending 2023-06-30 was $912.00K, a 67.96% increase year-over-year.
- Maravai LifeSciences Holdings, Inc. variable lease, cost for the quarter ending 2023-03-31 was $985.00K, a 87.62% increase year-over-year.
- Maravai LifeSciences Holdings, Inc. variable lease, cost for fiscal 2025 was $3.96M, a 6.90% increase from fiscal 2024.
- Maravai LifeSciences Holdings, Inc. variable lease, cost for fiscal 2024 was $3.71M, a 5.86% decline from fiscal 2023.
- Maravai LifeSciences Holdings, Inc. variable lease, cost for fiscal 2023 was $3.94M, a 43.69% increase from fiscal 2022.
- Maravai LifeSciences Holdings, Inc. variable lease, cost for fiscal 2022 was $2.74M, a 55.88% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $3.96M 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $3.71M 10-K · filed 2026-02-26 | |||
| 2023-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.04M derived: sum of 2 quarters · filed 2026-02-26 | $2.96M derived: sum of 3 quarters · filed 2026-02-26 | $3.94M 10-K · filed 2026-02-26 |
| 2023-09-30 | $1.02M 10-Q · filed 2023-11-08 | $1.93M derived: sum of 2 quarters · filed 2023-11-08 | $2.92M 10-Q · filed 2023-11-08 | $3.80M derived: sum of 4 quarters · filed 2025-03-18 |
| 2023-06-30 | $912.00K 10-Q · filed 2023-08-08 | $1.90M 10-Q · filed 2023-08-08 | $2.78M derived: sum of 3 quarters · filed 2025-03-18 | $3.57M derived: sum of 4 quarters · filed 2025-03-18 |
| 2023-03-31 | $985.00K 10-Q · filed 2023-05-09 | $1.87M derived: sum of 2 quarters · filed 2025-03-18 | $2.66M derived: sum of 3 quarters · filed 2025-03-18 | $3.20M derived: sum of 4 quarters · filed 2025-03-18 |
| 2022-12-31 | $884.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $1.67M derived: sum of 2 quarters · filed 2025-03-18 | $2.22M derived: sum of 3 quarters · filed 2025-03-18 | $2.74M 10-K · filed 2025-03-18 |
| 2022-09-30 | $790.00K 10-Q · filed 2023-11-08 | $1.33M derived: sum of 2 quarters · filed 2023-11-08 | $1.86M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $543.00K 10-Q · filed 2023-08-08 | $1.07M 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $525.00K 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | $1.76M 10-K · filed 2024-02-29 |